Amyloid-beta peptide decreases glutamate uptake in cultured astrocytes: involvement of oxidative stress and mitogen-activated protein kinase cascades.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Neuroscience

• Publication date

  2008-10-28

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.neuroscience.2008.08.022PMID 18790019
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Oxidative stress in Alzheimer disease

  2009cited by this paper
• Neurotoxic effect of oligomeric and fibrillar species of amyloid-beta peptide 1-42: involvement of endoplasmic reticulum calcium release in oligomer-induced cell death.

  2008cited by this paper
• Alterations of some membrane transport proteins in Alzheimer's disease: role of amyloid beta-peptide.

  2008cited by this paper
• Neurotoxic effect of oligomeric and fibrillar species of A 1-42 peptide. Involvement of ER calcium release in oligomers-induced cell death.

  2008cited by this paper
• Beta-amyloid causes downregulation of calcineurin in neurons through induction of oxidative stress.

  2007cited by this paper
• Neuroinflammation and Mitochondrial Dysfunction in Alzheimer's and Prion's Diseases

  2007cited by this paper
• Susceptibility of hippocampal neurons to Abeta peptide toxicity is associated with perturbation of Ca2+ homeostasis.

  2007cited by this paper
• Toll-like receptor 2 signaling is a mediator of apoptosis in herpes simplex virus-infected microglia

  2007cited by this paper
• Interactions between neurons and glia in aging and disease

  2007cited by this paper
• Microglial cells in astroglial cultures: a cautionary note

  2007cited by this paper
• Oxidative Stress and Mitogen-Activated Protein Kinase Phosphorylation Mediate Ammonia-Induced Cell Swelling and Glutamate Uptake Inhibition in Cultured Astrocytes

  2006cited by this paper
• Reactive Oxygen Species-Induced Activation of the MAP Kinase Signaling Pathways

  2006cited by this paper
• Mechanisms of Disease: astrocytes in neurodegenerative disease

  2006cited by this paper
• Astroglial Activation of Extracellular-Regulated Kinase in Early Stages of Alzheimer Disease

  2006cited by this paper
• Impaired Glutamate Transport in a Mouse Model of Tau Pathology in Astrocytes

  2006cited by this paper
• An endoplasmic-reticulum-specific apoptotic pathway is involved in prion and amyloid-beta peptides neurotoxicity.

  2006cited by this paper
• Alzheimer's disease

  2006cited by this paper
• Oxidative stress in Alzheimer's disease.

  2006cited by this paper
• Comparative study of microglia activation induced by amyloid‐beta and prion peptides: Role in neurodegeneration

  2006cited by this paper
• Differential effects of oligomeric and fibrillar amyloid-beta 1-42 on astrocyte-mediated inflammation.

  2005cited by this paper
• Differential modulation of the glutamate transporters GLT1, GLAST and EAAC1 by docosahexaenoic acid.

  2005cited by this paper
• β-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expression

  2005cited by this paper
• Astrocyte activation and reactive gliosis

  2005cited by this paper
• Fibroblast glutamate transport in aging and in AD: correlations with disease severity.

  2005cited by this paper
• Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-β peptides

  2004cited by this paper
• Microglia and Alzheimer's disease pathogenesis

  2004cited by this paper
• Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer's disease.

  2004cited by this paper
• β-Amyloid25-35 inhibits glutamate uptake in cultured neurons and astrocytes: modulation of uptake as a survival mechanism

  2004cited by this paper
• Small assemblies of unmodified amyloid β-protein are the proximate neurotoxin in Alzheimer’s disease

  2004cited by this paper
• Beta-amyloid and brain-derived neurotrophic factor, BDNF, up-regulate the expression of glutamate transporter GLT-1/EAAT2 via different signaling pathways utilizing transcription factor NF-kappaB.

  2003cited by this paper
• Neuronal and glial calcium signaling in Alzheimer's disease.

  2003cited by this paper
• Glutamatergic systems in Alzheimer's disease

  2003cited by this paper
• Amyloid beta protein enhances the clearance of extracellular L-glutamate by cultured rat cortical astrocytes.

  2003cited by this paper
• Adult mouse astrocytes degrade amyloid-beta in vitro and in situ.

  2003cited by this paper
• Amyloid β Peptide Specifically Promotes Phosphorylation and Nuclear Translocation of the Extracellular Signal-Regulated Kinase in Cultured Rat Cortical Astrocytes

  2003cited by this paper
• Involvement of calcineurin in the neurotoxic effects induced by amyloid‐beta and prion peptides

  2003cited by this paper
• Beta-amyloid and brain-derived neurotrophic factor, BDNF, up-regulate the expression of glutamate transporter GLT-1/EAAT2 via different signaling pathways utilizing transcription factor NF-κB

  2003cited by this paper
• The extracellular signal-regulated kinase cascade suppresses amyloid beta protein-induced promotion of glutamate clearance in cultured rat cortical astrocytes.

  2003cited by this paper
• Amyloid β protein enhances the clearance of extracellular l-glutamate by cultured rat cortical astrocytes

  2003cited by this paper
• Regulation of glial glutamate transporter expression by growth factors.

  2003cited by this paper
• Amyloid beta peptide specifically promotes phosphorylation and nuclear translocation of the extracellular signal-regulated kinase in cultured rat cortical astrocytes.

  2003cited by this paper
• Effects of estrogen treatment on glutamate uptake in cultured human astrocytes derived from cortex of Alzheimer's disease patients

  2002cited by this paper
• Neurodegenerative and Neuroprotective Effects of Tumor Necrosis Factor (TNF) in Retinal Ischemia: Opposite Roles of TNF Receptor 1 and TNF Receptor 2

  2002cited by this paper
• The Role of Mitogen-Activated Protein Kinase Pathways in Alzheimer’s Disease

  2002cited by this paper
• Aberrant Expression of the Glutamate Transporter Excitatory Amino Acid Transporter 1 (EAAT1) in Alzheimer's Disease

  2002cited by this paper
• Calcium dyshomeostasis and intracellular signalling in alzheimer's disease

  2002cited by this paper
• The Role of the MAP-Kinase Superfamily in β-Amyloid Toxicity

  2001cited by this paper
• Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies

  2001cited by this paper
• Changes in antioxidant enzyme expression in response to hydrogen peroxide in rat astroglial cells

  2001cited by this paper
• The glial glutamate transporter, GLT‐1, is oxidatively modified by 4‐hydroxy‐2‐nonenal in the Alzheimer's disease brain: the role of Aβ1–42

  2001cited by this paper
• The role of the MAP-kinase superfamily in beta-amyloid toxicity.

  2001cited by this paper
• β-Amyloid Peptides Are Cytotoxic to Astrocytes in Culture: A Role for Oxidative Stress

  2000cited by this paper
• Glutamate uptake is decreased in platelets from Alzheimer's disease patients

  2000cited by this paper
• Inflammation and Alzheimer's disease.

  2000cited by this paper
• Astrocyte glutamate transport: Review of properties, regulation, and physiological functions

  2000cited by this paper
• Abnormal glutamate transport function in mutant amyloid precursor protein transgenic mice.

  2000cited by this paper
• beta-amyloid peptides are cytotoxic to astrocytes in culture: a role for oxidative stress.

  2000cited by this paper
• The high-affinity glutamate transporters GLT1, GLAST, and EAAT4 are regulated via different signalling mechanisms.

  2000cited by this paper
• Amyloid β-peptide inhibits Na+-dependent glutamate uptake

  1999cited by this paper
• Amyloid beta-peptide inhibits Na+-dependent glutamate uptake.

  1999cited by this paper
• ERK/MAP kinase is chronically activated in human reactive astrocytes.

  1999cited by this paper
• Regulation of the glial glutamate transporter GLT‐1 by glutamate and δ‐opioid receptor stimulation

  1998cited by this paper
• Free radical oxidation of brain proteins in accelerated senescence and its modulation by N-tert-butyl-alpha-phenylnitrone.

  1997cited by this paper
• The inhibitory effects of beta-amyloid on glutamate and glucose uptakes by cultured astrocytes.

  1997cited by this paper
• Free radical oxidation of brain proteins in accelerated senescence and its modulation by N-tert-butyl-α-phenylnitrone

  1997cited by this paper
• High affinity glutamate transporters: regulation of expression and activity.

  1997cited by this paper
• Glutamate Transporter Alterations in Alzheimer Disease Are Possibly Associated with Abnormal APP Expression

  1997cited by this paper
• Impairment of excitatory amino acid transporter activity by oxidative stress conditions in retinal cells: effect of antioxidants

  1997cited by this paper
• Deficient glutamate tranport is associated with neurodegeneration in Alzheimer's disease

  1996cited by this paper
• Amyloid β Peptide (25–35) Inhibits Na+‐Dependent Glutamate Uptake in Rat Hippocampal Astrocyte Cultures

  1996cited by this paper
• Deficient glutamate transport is associated with neurodegeneration in Alzheimer's disease.

  1996cited by this paper
• Selective loss of glial glutamate transporter GLT‐1 in amyotrophic lateral sclerosis

  1995cited by this paper
• beta-Amyloid peptide-derived, oxygen-dependent free radicals inhibit glutamate uptake in cultured astrocytes: implications for Alzheimer's disease.

  1995cited by this paper
• Variant Forms of Neuronal Glutamate Transporter Sites in Alzheimer's Disease Cerebral Cortex

  1995cited by this paper
• β-Amyloid peptide-derived, oxygen-dependent free radicals inhibit glutamate uptake in cultured astrocytes: implications for Alzheimer's disease

  1995cited by this paper
• A new family of neurotransmitter transporters: the high‐affinity glutamate transporters

  1993cited by this paper

• Unraveling the molecular links: Alzheimer's disease-induced mechanisms of memory impairment: A narrative review

  2026cites this paper
• Astrocyte-Neuron Metabolic Synergies in Neurological Homeostasis and Disease

  2025cites this paper
• Neuroprotective role of GLT-1/EAAT2 in glutamate-induced excitotoxicity.

  2025cites this paper
• Associations Between Diabetes Mellitus and Neurodegenerative Diseases

  2025cites this paper
• Modeling of neuronal hyperexcitability modulated by Aβ-mediated astrocyte dysfunction.

  2025cites this paper
• Dual glymphatic roles in first-episode schizophrenia and clinical high-risk for psychosis: Evidence from diffusion tensor image analysis along the perivascular space index.

  2025cites this paper
• AMPA receptors in the evolving synapse: structure, function, and disease implications

  2025cites this paper
• From Homeostasis to Neuroinflammation: Insights into Cellular and Molecular Interactions and Network Dynamics

  2025cites this paper
• Ecdysterone and High-Intensity Interval Training Mitigate Alzheimer’s Pathology in Rats: Impacts on Depression, Synaptic Plasticity, and Neuroinflammation

  2025cites this paper
• Reactive Astrocytes with Reduced Function of Glutamate Transporters in the App NL‑G‑F Knock-in Mice

  2025cites this paper
• Idiopathic focal epilepsy in children and adolescents: roles of perinatal pain, amyloid-β oligomers and DHA (omega-3 fatty acid) deficiency

  2025cites this paper
• Donepezil and Memantine Derivatives for Dual-Function and Prodrug Applications in Alzheimer's Disease.

  2025cites this paper
• PS1/gamma-secretase acts as rogue chaperone of glutamate transporter EAAT2/GLT-1 in Alzheimer’s disease

  2024cites this paper
• Aβ-mediated synaptic glutamate dynamics and calcium dynamics in astrocytes associated with Alzheimer’s disease

  2024cites this paper
• Identification of PS1/gamma-secretase and glutamate transporter GLT-1 interaction sites

  2024cites this paper
• AAV8 vector induced gliosis following neuronal transgene expression

  2024cites this paper
• Single cell transcriptome analysis of the THY-Tau22 mouse model of Alzheimer’s disease reveals sex-dependent dysregulations

  2024cites this paper
• Morphofunctional Investigation in a Transgenic Mouse Model of Alzheimer’s Disease: Non-Reactive Astrocytes Are Involved in Aβ Load and Reactive Astrocytes in Plaque Build-Up

  2023cites this paper
• PS1/gamma-secretase acts as rogue chaperone of glutamate transporter EAAT2/GLT-1 in Alzheimer’s disease

  2023cites this paper
• FGF-18 alleviates memory impairments and neuropathological changes in a rat model of Alzheimer's disease.

  2023cites this paper
• Ceftriaxone ameliorates hippocampal synapse loss by inhibiting microglial/macrophages activation in glial glutamate transporter-1 dependent manner in the APP/PS1 mouse model of Alzheimer's disease.

  2023cites this paper
• Neuroinflammation: An astrocyte perspective

  2023cites this paper
• Astrocyte Responses Influence Local Effects of Whole‐Brain Magnetic Stimulation in Parkinsonian Rats

  2023influential citation
• Human Alzheimer’s disease reactive astrocytes exhibit a loss of homeostastic gene expression

  2023cites this paper
• The Essential Role of Astrocytes in Neurodegeneration and Neuroprotection.

  2023cites this paper
• Identification of PS1/gamma-secretase and glutamate transporter GLT-1 interaction sites

  2023cites this paper
• Early chronic suppression of microglial p38α in a model of Alzheimer’s disease does not significantly alter amyloid-associated neuropathology

  2023cites this paper
• Astrocytes as Neuroimmunocytes in Alzheimer’s Disease: A Biochemical Tool in the Neuron–Glia Crosstalk along the Pathogenetic Pathways

  2023cites this paper
• Astrocyte energy and neurotransmitter metabolism in Alzheimer's disease: integration of the glutamate/GABA-glutamine cycle.

  2022cites this paper
• Protective Effect of Low Dose of Methamphetamine on The Amount of Extracellular Glutamine in Primary Fetal Human Astrocytes Induced by Amyloid Beta

  2022cites this paper
• Diminished motor neuron activity driven by abnormal astrocytic GLAST glutamate transporter activity in spinal muscular atrophy is not fully restored after lentiviral SMN delivery

  2022cites this paper
• Cerebral Glutamate Regulation and Receptor Changes in Perioperative Neuroinflammation and Cognitive Dysfunction

  2022cites this paper
• Cortical Hyperexcitability in the Driver’s Seat in ALS

  2022cites this paper
• NRSF regulates age-dependently cognitive ability and its conditional knockout in APP/PS1 mice moderately alters ad-like pathology.

  2022cites this paper
• Amyloid Beta Peptide-Mediated Alterations in Mitochondrial Dynamics and its Implications for Alzheimer's Disease.

  2022cites this paper
• Compromised Astrocyte Swelling/Volume Regulation in the Hippocampus of the Triple Transgenic Mouse Model of Alzheimer’s Disease

  2022cites this paper
• Role of Aβ in Alzheimer’s-related synaptic dysfunction

  2022cites this paper
• Metabotropic glutamate receptor 3 as a potential therapeutic target for psychiatric and neurological disorders.

  2022cites this paper
• Aß Pathology and Neuron–Glia Interactions: A Synaptocentric View

  2022cites this paper
• Crosstalk Between the Oxidative Stress and Glia Cells After Stroke: From Mechanism to Therapies

  2022cites this paper
• Do tau-synaptic long-term depression interactions in the hippocampus play a pivotal role in the progression of Alzheimer’s disease?

  2022cites this paper
• The Role of Astrocytes in Synapse Loss in Alzheimer's Disease: A Systematic Review

  2022cites this paper
• Complex processes underlying the dynamic changes of D-serine level in AD brains.

  2022cites this paper
• Metabolic, Phenotypic, and Neuropathological Characterization of the Tg4-42 Mouse Model for Alzheimer’s Disease

  2021cites this paper
• Integrative Functional Genomic Analysis of Molecular Signatures and Mechanistic Pathways in the Cell Cycle Underlying Alzheimer's Disease

  2021cites this paper
• The Many Faces of Astrocytes in Alzheimer's Disease

  2021cites this paper
• Association Between Adenosine A2A Receptors and Connexin 43 Regulates Hemichannels Activity and ATP Release in Astrocytes Exposed to Amyloid-β Peptides

  2021cites this paper
• α-Synuclein Oligomers Induce Glutamate Release from Astrocytes and Excessive Extrasynaptic NMDAR Activity in Neurons, Thus Contributing to Synapse Loss

  2021cites this paper
• Amyloid-β1-40 differentially stimulates proliferation, activation of oxidative stress and inflammatory responses in male and female hippocampal astrocyte cultures.

  2021cites this paper
• The Role of Neuroglial Metabotropic Glutamate Receptors in Alzheimer’s Disease

  2021cites this paper
• Glutamate Metabolism in Mitochondria is Closely Related to Alzheimer’s Disease

  2021cites this paper
• Single-cell brain atlas of Parkinson's disease mouse model.

  2021cites this paper
• P.0442 Involvement of beta amyloid 1-42 in amino acid transportation into astrocytes and immunoreactive hypofunction

  2021cites this paper
• Entering a new era of quantifying glutamate clearance in health and disease

  2021cites this paper
• Integrative genomic analysis of PPP3R1 in Alzheimer’s disease: a potential biomarker for predictive, preventive, and personalized medical approach

  2021cites this paper
• Type 2 Diabetes Mellitus Easily Develops into Alzheimer’s Disease via Hyperglycemia and Insulin Resistance

  2021cites this paper
• The Neurogenic Niche in Alzheimer's disease.

  2021cites this paper
• Roles of astrocytes in response to aging, Alzheimer's Disease and Multiple Sclerosis.

  2021cites this paper
• The Effects and Mechanisms of Phytochemicals on Alzheimer’s Disease Neuropathology

  2021cites this paper
• Noradrenaline in the aging brain: Promoting cognitive reserve or accelerating Alzheimer's disease?

  2021cites this paper
• Neuroinflammation: Integrated Nervous Tissue Response through Intercellular Interactions at the “Whole System” Scale

  2021cites this paper
• Amyloid Beta-Mediated Changes in Synaptic Function and Spine Number of Neocortical Neurons Depend on NMDA Receptors

  2021cites this paper
• l‐α‐aminoadipate causes astrocyte pathology with negative impact on mouse hippocampal synaptic plasticity and memory

  2021cites this paper
• Glia: A major player in glutamate–GABA dysregulation‐mediated neurodegeneration

  2021cites this paper
• Glutamate metabolism and recycling at the excitatory synapse in health and neurodegeneration.

  2021cites this paper
• A mechanistic hypothesis for the impairment of synaptic plasticity by soluble Aβ oligomers from Alzheimer’s brain

  2020cites this paper
• Efficacy of probiotics on cognition, and biomarkers of inflammation and oxidative stress in adults with Alzheimer’s disease or mild cognitive impairment — a meta-analysis of randomized controlled trials

  2020cites this paper
• Using human induced pluripotent stem cells (hiPSCs) to investigate the mechanisms by which Apolipoprotein E (APOE) contributes to Alzheimer's disease (AD) risk.

  2020cites this paper
• The role of astrocytes in oxidative stress of central nervous system: A mixed blessing

  2020cites this paper
• Integrated profiling of single cell epigenomic and transcriptomic landscape of Parkinson’s disease mouse brain

  2020cites this paper
• Astrocyte Crosstalk in CNS Inflammation.

  2020cites this paper
• Amyloid-ß peptides inhibit the expression of AQP4 and glutamate transporter EAAC1 in insulin-treated C6 glioma cells

  2020cites this paper
• Exogenous Adenosine Antagonizes Excitatory Amino Acid Toxicity in Primary Astrocytes

  2020cites this paper
• Anti-Amnesic Effect of Walnut via the Regulation of BBB Function and Neuro-Inflammation in Aβ1-42-Induced Mice

  2020cites this paper
• The Regulation of Astrocytic Glutamate Transporters in Health and Neurodegenerative Diseases

  2020cites this paper
• The Interplay between Diabetes and Alzheimer’s Disease—In the Hunt for Biomarkers

  2020cites this paper
• mGluR5 Contribution to Neuropathology in Alzheimer Mice Is Disease Stage-Dependent.

  2020cites this paper
• Astrocyte responses to nanomaterials: functional changes, pathological changes and potential applications.

  2020cites this paper
• NitroSynapsin ameliorates hypersynchronous neural network activity in Alzheimer hiPSC models

  2020cites this paper
• Amyloid‐beta1–42 induced glutamatergic receptor and transporter expression changes in the mouse hippocampus

  2020cites this paper
• Specific knockdown of hippocampal astroglial EphB2 improves synaptic function via inhibition of D-serine secretion in APP/PS1 mice.

  2019cites this paper
• Sex-specific pathophysiological mGluR5-dependent Aβ oligomer signaling in Alzheimer mice

  2019cites this paper
• Astroglia in Alzheimer's Disease.

  2019cites this paper
• C5aR agonist enhances phagocytosis of fibrillar and non-fibrillar Aβ amyloid and preserves memory in a mouse model of familial Alzheimer’s disease

  2019cites this paper
• The mechanism of GLT-1 mediating cerebral ischemic injury depends on the activation of p38 MAPK.

  2019cites this paper
• PRECLINICAL TARGETING OF TREM2 FOR THE TREATMENT OF ALZHEIMER'S DISEASE-TYPE PATHOLOGY IN A TRANSGENIC MOUSE MODEL

  2019cites this paper
• Cajaninstilbene Acid Ameliorates Cognitive Impairment Induced by Intrahippocampal Injection of Amyloid-β1–42 Oligomers

  2019cites this paper
• Biomarkers of Alzheimer's Disease

  2019cites this paper
• Potential Astrocytic Receptors and Transporters in the Pathogenesis of Alzheimer’s Disease

  2019cites this paper
• Glutamatergic synaptic plasticity and dysfunction in Alzheimer disease

  2018cites this paper
• 11 Role of Astrocytes in Neurodegenerative Diseases

  2018cites this paper
• Constitutive downregulation protein kinase C epsilon in hSOD1G93A astrocytes influences mGluR5 signaling and the regulation of glutamate uptake

  2018cites this paper
• Astrocytic glutamatergic transporters are involved in Aβ-induced synaptic dysfunction.

  2018cites this paper
• Ceftriaxone Improves Cognitive Function and Upregulates GLT-1-Related Glutamate-Glutamine Cycle in APP/PS1 Mice

  2018cites this paper
• Novel interaction between Alzheimer’s disease-related protein presenilin 1 and glutamate transporter 1

  2018cites this paper
• Alzheimer's Disease and Type 2 Diabetes: A Critical Assessment of the Shared Pathological Traits

  2018cites this paper
• Role of p38/MAPKs in Alzheimer’s disease: implications for amyloid beta toxicity targeted therapy

  2018cites this paper
• Alzheimer's Disease: Recent Concepts on the Relation of Mitochondrial Disturbances, Excitotoxicity, Neuroinflammation, and Kynurenines.

  2018cites this paper
• Melatonin in Synaptic Impairments of Alzheimer’s Disease

  2018cites this paper
• Effects and mechanisms of actions of phytochemicals on Alzheimer's disease neuropathology.

  2018cites this paper